Direct-acting antiviral-based triple therapy on alpha-fetoprotein level in chronic hepatitis C patients

doi:10.3748/wjg.v21.i15.4696

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 15

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6720)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-4) series.

Item

Count

PDF

366

WORD

260

HTML

2978

Figures (1-4)

196

Tables (1-4)

182

Sum=3982

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1027

Download

1711

Sum=2738

Apr 21, 2015 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Gastroenterol. Apr 21, 2015; 21(15): 4696-4706
Published online Apr 21, 2015. doi: 10.3748/wjg.v21.i15.4696

Full Size Figure Download Figure

Figure 1 Flowchart of the study design. Dual therapy: Pegylated-interferon-α and ribavirin; HBV: Hepatitis B virus; HCC: Hepatocellular carcinoma; HIV: Human immunodeficiency virus; NVR: Non-virological response; Triple therapy: Telaprevir-based therapy combined with pegylated-interferon-α and ribavirin.

Citation: Takayama K, Furusyo N, Ogawa E, Ikezaki H, Shimizu M, Murata M, Hayashi J. Direct-acting antiviral-based triple therapy on alpha-fetoprotein level in chronic hepatitis C patients. World J Gastroenterol 2015; 21(15): 4696-4706
URL: https://www.wjgnet.com/1007-9327/full/v21/i15/4696.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i15.4696